University of Tampa Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2012
NCT01508338
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 3